Table 4 Evolution of urinary melatonin, 6 sulfatoxymelatonin, and melatonin/6 sulfatoxymelatonin ratio
From: A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial
Active group | Placebo group | |||||
|---|---|---|---|---|---|---|
Baseline | End of Study | Difference | Baseline | End of Study | Difference | |
Melatonin (ng/h), | 8.1 (5.9) | 10.3 (11.5) | +2.2 (11.3) | 8.0 (5.4) | 7.3 (5.2) | -0.7 (5.0) |
aMT6S (ng/h) | 362.9 (256.0) | 333.4 (206.2) | -29.4 (138.2) | 291.0 (144.4) | 294.3 (144.5) | +3.3 (111.2) |
Mel/aMT6S* | 0,0301 (0,0329) | 0,0339 (0,0327) | +0,004 (0,037) | 0,0301 (0,0201) | 0,0319 (0,0327) | +0,002 (0,030) |